A growing number of doctors are advocating to rename low-grade prostate cancer to reduce unnecessary aggressive treatments that can lead to debilitating side effects. About one-quarter of men diagnosed with prostate cancer have the lowest-risk form, yet studies show 40% opt for surgery or radiation despite recommendations for active surveillance.
The push comes amid mounting evidence that careful monitoring is effective in managing low-grade cases. A U.K. study of 1,600 men found similar 15-year mortality rates between those who chose surgery, radiation or surveillance. Some doctors oppose the change, warning it could reduce patient compliance with follow-up care.
Read more of this story at Slashdot.